Introduction
What causes systemic sclerosis? The condition arises from a combination of immune system dysfunction, blood vessel injury, and abnormal activation of fibroblasts that produce excess connective tissue. In other words, systemic sclerosis develops when the body’s normal mechanisms for immune defense, vascular repair, and tissue remodeling become persistently misregulated. There is no single cause in most people. Instead, the disease usually reflects an interaction between genetic susceptibility and external or internal triggers that push these biological systems into a self-perpetuating cycle of inflammation, vascular damage, and fibrosis.
Systemic sclerosis, also called scleroderma, is best understood as a disorder of connective tissue biology. The skin is often affected, but the same underlying processes can involve the lungs, heart, kidneys, digestive tract, and blood vessels. The main contributors can be grouped into biological mechanisms, primary causes, risk factors, and triggering conditions that help initiate or amplify the disease process.
Biological Mechanisms Behind the Condition
The core mechanism in systemic sclerosis is a three-part process: immune activation, vascular injury, and fibrosis. Under normal circumstances, the immune system responds to threat and then quiets down, blood vessels repair minor damage, and fibroblasts help rebuild tissue only when needed. In systemic sclerosis, these processes fail to switch off appropriately.
Immune dysregulation is often one of the earliest events. Immune cells become overactive and release inflammatory signals such as cytokines and growth factors. These signals alter the behavior of vascular cells and fibroblasts. At the same time, the endothelium, which lines blood vessels, becomes injured and dysfunctional. Healthy endothelium normally helps regulate vessel tone, blood flow, clotting, and repair. When it is damaged, vessels become more prone to narrowing, reduced blood flow, and abnormal signaling to surrounding tissues.
Fibrosis is the final major outcome. Fibroblasts, which ordinarily produce collagen and other structural components during wound repair, become persistently activated and behave as if tissue is injured even when no ongoing wound exists. They deposit excessive collagen and extracellular matrix in the skin and internal organs. This thickens and stiffens tissues, impairing function. In systemic sclerosis, the fibrotic response is not simply a healing response that has gone too far; it is driven by ongoing immune and vascular abnormalities that keep fibroblasts in an activated state.
Several molecular pathways are involved, including transforming growth factor beta, platelet-derived growth factor, and other profibrotic mediators. These signals promote collagen production, reduce normal collagen breakdown, and encourage the transformation of fibroblasts into myofibroblasts, which are especially active matrix-producing cells. Abnormal vasoconstriction and reduced nitric oxide availability further worsen tissue oxygenation, which can reinforce inflammation and fibrosis. This creates a feedback loop in which vascular injury, immune activation, and connective tissue deposition sustain one another.
Primary Causes of Systemic Sclerosis
There is no single universally proven cause, but certain biological drivers are strongly associated with the development of systemic sclerosis. The most important of these are autoimmune dysfunction, genetic susceptibility, and environmental exposure.
Autoimmune dysfunction is central to the disease. In systemic sclerosis, the immune system produces autoantibodies and inflammatory mediators that target the body’s own tissues. These autoantibodies are not usually directly destructive in the way a toxin might be, but they reflect and participate in a broader immune misfire. Immune cells interact with blood vessels and connective tissue, promoting endothelial damage and fibroblast activation. This is why systemic sclerosis is considered an autoimmune connective tissue disease rather than a purely fibrotic disorder.
Genetic susceptibility does not cause the disease by itself in most cases, but it increases the likelihood that immune and repair pathways will become dysregulated. Certain inherited variants in immune-regulating genes, especially those related to HLA function and interferon signaling, are linked to higher risk. These genetic differences may affect how the immune system recognizes self and non-self, how strongly inflammatory signals are produced, and how tissue repair is controlled after injury. The result is a body that may be more reactive to triggers and less able to stop inflammatory and fibrotic responses once they begin.
Environmental exposures can provide the initiating injury that begins the disease process. These exposures may damage blood vessels, alter immune function, or both. Organic solvents, silica dust, and certain occupational exposures have been associated with systemic sclerosis in some studies. The mechanism is thought to involve repeated microvascular injury, oxidative stress, and immune activation. When endothelial cells are repeatedly damaged, they can expose immune targets and release danger signals that intensify inflammation. In people with genetic susceptibility, this may be enough to set off the chronic disease process.
Contributing Risk Factors
Several additional factors can increase the likelihood of developing systemic sclerosis or influence how it manifests. These do not necessarily cause the disease on their own, but they can raise biologic vulnerability.
Genetic influences extend beyond a small number of high-risk genes. Family history of autoimmune disease suggests a broader inherited tendency toward immune dysregulation. Multiple genes may contribute small effects, influencing antigen presentation, lymphocyte activation, interferon responses, and tissue repair pathways. This polygenic pattern helps explain why the disease is uncommon overall, yet clusters in some families and populations.
Environmental exposures include silica dust, polyvinyl chloride, organic solvents, and sometimes repetitive vibration or occupational microtrauma. These exposures can injure endothelial cells, promote oxidative stress, and alter immune signaling. Oxidative stress is especially relevant because it can damage cell membranes, proteins, and DNA, making vascular injury more persistent and difficult to repair. Repeated exposure may keep the inflammatory cycle active long enough for fibrosis to become established.
Infections are not considered a direct cause in most cases, but infectious triggers have been proposed because some infections can stimulate immune responses that cross-react with self tissues. Viral infections, in particular, may alter immune regulation or induce chronic interferon signaling. In genetically predisposed individuals, an infection could function as an immune trigger that initiates the abnormal response cascade. The evidence is suggestive rather than definitive, but the concept fits the autoimmune pattern of the disease.
Hormonal changes may help explain the marked female predominance of systemic sclerosis. Estrogen and other sex-related hormones influence immune activity, vascular tone, and connective tissue behavior. Female immune systems often mount stronger humoral and cellular responses, which may increase susceptibility to autoimmune disease. Hormonal effects on endothelial function and fibroblast signaling may also contribute to the tendency toward vascular and fibrotic pathology.
Lifestyle factors are usually indirect rather than primary causes. Smoking, for example, can damage blood vessels, worsen oxygen delivery, and amplify oxidative stress. Poor overall vascular health may make the endothelium more vulnerable to injury. Although lifestyle factors alone do not explain systemic sclerosis, they can intensify the biologic conditions that favor its development or progression.
How Multiple Factors May Interact
Systemic sclerosis usually emerges when several biologic influences converge. A person may inherit immune-related variants that create a background of susceptibility, then encounter an environmental exposure that injures the endothelium. That injury may provoke immune activation, which in turn releases cytokines and profibrotic mediators. These mediators stimulate fibroblasts, and the fibroblasts deposit collagen in excess. Meanwhile, ongoing vascular dysfunction reduces blood flow and oxygen delivery, making tissue repair abnormal and reinforcing inflammation.
This interaction is important because each system affects the others. Immune activation can worsen vascular injury. Vascular injury can amplify fibrosis. Fibrosis can impair organ function and local blood flow, increasing tissue stress and maintaining the inflammatory state. Once this loop is established, the disease can continue even if the original trigger is no longer present. This self-amplifying nature is one reason systemic sclerosis can progress over time rather than remaining a short-lived inflammatory episode.
Variations in Causes Between Individuals
The causes of systemic sclerosis differ from one person to another because the disease is not a single uniform process. In some individuals, inherited immune traits may be the dominant factor, while in others a particular exposure appears to play a larger role. Some people develop mainly skin involvement, while others have early internal organ disease, suggesting that the same underlying biology may be shaped by different starting points.
Genetics influence how strongly a person’s immune system reacts and how readily fibroblasts enter an activated state. Age may affect vascular resilience and immune regulation, although systemic sclerosis can develop in adults across a wide age range. Health status, especially existing vascular disease or other autoimmune tendencies, may lower the threshold for disease development. Environmental exposure history also matters because repeated or prolonged contact with triggers increases the chance of endothelial damage and immune activation.
These differences help explain why systemic sclerosis is heterogeneous. Some patients may have a clear exposure history, while others have no obvious trigger at all. In many cases, the exact initiating event is never identified because the disease may begin long before symptoms become noticeable.
Conditions or Disorders That Can Lead to Systemic Sclerosis
Some medical conditions and related disorders may contribute to or precede systemic sclerosis by altering immune regulation or vascular integrity. Other autoimmune diseases can occur alongside it and may reflect a shared predisposition. For example, autoimmune thyroid disease, Sjögren syndrome, or polymyositis may coexist with systemic sclerosis because the immune system in affected individuals is already biased toward autoimmunity. This does not mean one disease directly causes the other, but it suggests a common underlying immune environment.
Chronic vascular disorders may also contribute indirectly by placing ongoing stress on blood vessels. Repeated ischemia, endothelial dysfunction, or microvascular injury can prime tissues for abnormal repair responses. In some occupational settings, toxin-related illnesses or silica-related lung disease may precede systemic sclerosis-like changes because they repeatedly injure tissues and stimulate immune pathways. Likewise, chronic inflammatory states in general may create a biologic setting in which profibrotic signals are more likely to dominate.
In certain cases, systemic sclerosis can overlap with other connective tissue diseases, and this overlap may blur the line between a trigger and a preexisting disorder. The shared physiology involves autoimmunity, microvascular damage, and tissue remodeling abnormalities. These relationships are important because they show that systemic sclerosis often develops in a broader context of immune and connective tissue instability rather than from a single isolated event.
Conclusion
Systemic sclerosis develops through a complex combination of immune dysfunction, blood vessel injury, and excessive fibrosis. The strongest contributors are autoimmune activity, inherited susceptibility, and environmental exposures that damage the endothelium or disturb immune regulation. Additional factors such as infections, hormonal influences, smoking, and occupational toxins may increase risk or intensify the underlying biologic process.
Understanding the causes of systemic sclerosis requires seeing it as a disease of interacting systems rather than a single organ problem. The immune system becomes persistently activated, the vasculature loses normal repair capacity, and fibroblasts produce too much collagen. These processes reinforce one another and can affect the skin and internal organs. Explaining the condition in this way clarifies why systemic sclerosis develops, why it varies between individuals, and why its course can be so difficult to predict.